|
TMEM127 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.144400E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.622400E-01 |
| Normal-vs-Stage2 |
2.734600E-01 |
| Normal-vs-Stage3 |
7.578400E-01 |
| Normal-vs-Stage4 |
8.385200E-01 |
| Stage1-vs-Stage2 |
6.781000E-01 |
| Stage1-vs-Stage3 |
4.234400E-01 |
| Stage1-vs-Stage4 |
4.695200E-01 |
| Stage2-vs-Stage3 |
3.748200E-01 |
| Stage2-vs-Stage4 |
3.712800E-01 |
| Stage3-vs-Stage4 |
9.247000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.634200E-01 |
| Normal-vs-AfricanAmerican |
1.731980E-01 |
| Normal-vs-Asian |
1.055200E-01 |
| Caucasian-vs-AfricanAmerican |
5.171200E-01 |
| Caucasian-vs-Asian |
3.206800E-01 |
| AfricanAmerican-vs-Asian |
9.219000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.590800E-01 |
| Normal-vs-Female |
3.007200E-01 |
| Male-vs-Female |
3.335800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.298000E-01 |
| Normal-vs-Age(41-60Yrs) |
4.052600E-01 |
| Normal-vs-Age(61-80Yrs) |
8.232200E-01 |
| Normal-vs-Age(81-100Yrs) |
5.491400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.196400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.525000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.915400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.470200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.047600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.288200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.529600E-01 |
| Classical-VS-Follicular |
1.188690E-04 |
| Classical-VS-Other |
2.076300E-02 |
| Classical-VS-Normal |
5.437900E-02 |
| Tall-VS-Follicular |
2.346600E-01 |
| Tall-VS-Other |
1.074170E-01 |
| Tall-VS-Normal |
7.195400E-01 |
| Follicular-VS-Other |
3.949200E-01 |
| Follicular-VS-Normal |
2.488000E-01 |
| Other-VS-Normal |
1.082610E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.007800E-01 |
| Normal-vs-N1 |
3.609800E-01 |
| N0-vs-N1 |
1.096560E-01 |
|
|
